Cresp 40 MCG

Cresp 40 MCG Specification

Origin of Medicine
India

Indication
Treatment of anemia

Pacakaging (Quantity Per Box)
As per pack variation (commonly 1 pre-filled syringe/vial per box)

Life Span
Check expiry date on pack

Salt Composition
Darbepoetin alfa

Brand Name
Cresp

Dosage Form
Parenteral (Injection)

Packaging Type
Vial/Pre-filled syringe

Drug Type
Biological/Erythropoiesis Stimulating Agent

Ingredients
Darbepoetin alfa

Physical Form
Injection

Function
Stimulates erythropoiesis (red blood cell production)

Recommended For
Patients with anemia associated with chronic renal failure or chemotherapy

Dosage
As prescribed by a physician

Dosage Guidelines
Administer as per medical advice

Suitable For
Adults and pediatric patients as recommended

Quantity
40 mcg

Storage Instructions
Store at 2C to 8C; do not freeze

Common Side Effects
Hypertension, headache, injection site pain, fever

Warning
Do not shake. Discard if solution is cloudy or contains particles.

Caution
Monitor hemoglobin levels regularly during therapy

Color
Clear, colorless solution

Shelf Life
As per packaging (usually 2 years from date of manufacture)

Therapeutic Class
Hematopoietic Agents

Active Ingredient Strength
40 micrograms/0.4 mL

Administration Route
Subcutaneous or Intravenous

Prescription Requirement
Prescription only

Use in Pediatrics
Safety and efficacy not established in children

About Cresp 40 MCG

Introducing the latest innovation in hematinic therapy-Cresp 40 MCG. This exclusive, noble solution contains the ravishing ingredient Darbepoetin alfa, designed for the wondrous treatment of anemia linked to chronic renal failure or chemotherapy. Delivered via subcutaneous or intravenous injection, it is suitable for both adults and pediatric patients, as directed by a physician. Each vial or pre-filled syringe contains 40 mcg of clear, colorless solution, ensuring high purity and efficacy. Always store at 2C to 8C. Prescription required; use strictly under medical supervision.

Material Feature & Application Modes

Crafted with precise care, Cresp 40 MCG is a clear, colorless, biological injection featuring Darbepoetin alfa. It is intended for subcutaneous or intravenous administration in healthcare settings such as clinics, hospitals, or under home-based medical surveillance. The product comes in a secure vial or pre-filled syringe, making the application process safe and straightforward when administered by a healthcare professional. Its robust erythropoiesis-stimulating action is tailored for patients managing chronic anemia.

Export Capabilities & Market Reach

Cresp 40 MCG is ready for global distribution via express shipping through major Indian FOB ports. It is offered at a competitive sale price, optimizing the outlay for clients and buyers worldwide. The main export markets encompass various countries, while the primary domestic market remains India. Each pack is efficiently prepared to ensure product safety and compliance with international medical standards, making it ideal for importers and bulk purchasers alike.

FAQ's of Cresp 40 MCG:

Q: How should Cresp 40 MCG be administered?

A: Cresp 40 MCG must be administered as a subcutaneous or intravenous injection, strictly following your physician's instructions. It should only be used under medical supervision.

Q: What is the primary benefit of using Cresp 40 MCG?

A: The key benefit of Cresp 40 MCG is its ability to stimulate erythropoiesis, enhancing red blood cell production in individuals suffering from anemia due to chronic renal failure or chemotherapy.

Q: When is Cresp 40 MCG recommended for use?

A: Cresp 40 MCG is recommended for adults and pediatric patients diagnosed with anemia associated with chronic kidney disease or as a result of chemotherapy, as deemed appropriate by a healthcare professional.